Sino Biopharmaceutical Limited
OTC: SBHMY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- S. Y. Tse
- Employees
- 24,379
- Headquarters
- Wan Chai, Hong Kong SAR China
- IPO year
- 2017
- Market cap
- $11.3B
- Website
- https://www.sinobiopharm.com
Loading SBHMY…
Loading profile data…Frequently asked questions about SBHMY
What does Sino Biopharmaceutical Limited (SBHMY) do?
Sino Biopharmaceutical Limited operates as a prominent research and development-centric pharmaceutical conglomerate in the People's Republic of China, functioning as an investment holding company. Its operations are organized into three primary divisions: Modernized Chinese and Chemical Medicines, Investment activities, and other varied business...
Where does SBHMY trade?
Sino Biopharmaceutical Limited (SBHMY) trades on the Other OTC.
What sector is SBHMY in?
Sino Biopharmaceutical Limited (SBHMY) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Sino Biopharmaceutical Limited?
S. Y. Tse is the chief executive officer of Sino Biopharmaceutical Limited (SBHMY).
Where is Sino Biopharmaceutical Limited headquartered?
Sino Biopharmaceutical Limited is headquartered in Hong Kong SAR China.
Does SBHMY pay a dividend?
Yes — Sino Biopharmaceutical Limited (SBHMY) paid a trailing twelve-month dividend of USD 0.13 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SBHMY go public?
Sino Biopharmaceutical Limited (SBHMY) completed its initial public offering in 2017.
Is SBHMY an ADR?
Yes — SBHMY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Sino Biopharmaceutical Limited reporting and dividends follow the underlying issuer.